FHIR IG analytics| Package | hl7.fhir.be.lab |
| Resource Type | Bundle |
| Id | Bundle-antibiogramAsBundleCollection.json |
| FHIR Version | R4 |
No resources found
No resources found
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "Bundle",
"id": "antibiogramAsBundleCollection",
"identifier": {
"system": "urn:ietf:rfc:3986",
"value": "urn:uuid:0c3151bd-1cbf-4d91-b04d-cd9187a4c6e0"
},
"type": "collection",
"entry": [
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d34",
"resource": {
"resourceType": "DiagnosticReport",
"id": "diagnosticreport50",
"meta": {
"versionId": "1",
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-laboratory-report"
]
},
"language": "en",
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"system": "https://www.ehealth.fgov.be/lab-report/diagnostic-report-id",
"value": "11530231003.2015110413180000000"
}
],
"basedOn": [
{
"reference": "ServiceRequest/servicerequest50"
}
],
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "LAB",
"display": "Laboratory"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "MB",
"display": "Microbiology"
}
]
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "18769-0",
"display": "Microbial susceptibility tests Set"
}
],
"text": "Microbial susceptibility tests"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-03T13:18:00+01:00",
"issued": "2015-11-04T13:18:00+01:00",
"performer": [
{
"reference": "Organization/organization10"
}
],
"resultsInterpreter": [
{
"reference": "Practitioner/practitioner11"
}
],
"specimen": [
{
"reference": "Specimen/specimen50"
}
],
"result": [
{
"reference": "Observation/org51"
},
{
"reference": "Observation/org52"
},
{
"reference": "Observation/dr50-mrsa"
},
{
"reference": "Observation/dr50-mrgn"
}
],
"conclusion": "This is our conclusion"
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d36",
"resource": {
"resourceType": "Specimen",
"id": "specimen50",
"meta": {
"versionId": "1",
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-specimen-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"system": "https://www.GTL-LABO.be/",
"value": "1"
}
],
"status": "available",
"type": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "258529004",
"display": "Throat swab"
}
],
"text": "A string can be added to nuance or explain."
},
"receivedTime": "2015-11-04",
"note": [
{
"text": "Some extra relevant information concerning the specimen"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d37",
"resource": {
"resourceType": "Observation",
"id": "org51",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "73960-7",
"display": "Bacteria identified in Mouth by Culture"
}
]
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "243301005",
"display": "Morganella morganii"
}
]
},
"specimen": {
"reference": "Specimen/specimen50"
},
"hasMember": [
{
"reference": "Observation/org51-ampicilin"
},
{
"reference": "Observation/org51-trimethoprim-sulfamethoxazole"
},
{
"reference": "Observation/org51-nitrofurantoin"
},
{
"reference": "Observation/org51-cefuroxime"
},
{
"reference": "Observation/org51-gentamicin"
},
{
"reference": "Observation/org51-colistin"
},
{
"reference": "Observation/org51-temocillin"
},
{
"reference": "Observation/org51-fosfomycin"
},
{
"reference": "Observation/org51-levofloxacin"
},
{
"reference": "Observation/org51-ofloxacin"
},
{
"reference": "Observation/org51-amoxicillin-clavulanate"
},
{
"reference": "Observation/org51-amikacin"
},
{
"reference": "Observation/org51-piperacillin-tazobactam"
},
{
"reference": "Observation/org51-ceftriaxone"
},
{
"reference": "Observation/org51-cefotaxime"
},
{
"reference": "Observation/org51-ceftazidime"
},
{
"reference": "Observation/org51-meropenem"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d38",
"resource": {
"resourceType": "Observation",
"id": "org51-ampicilin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "29-9",
"display": "Ampicillin [Susceptibility] by Disk diffusion (KB)"
}
],
"text": "Ampicillin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "R",
"display": "Resistant"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d39",
"resource": {
"resourceType": "Observation",
"id": "org51-trimethoprim-sulfamethoxazole",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "516-5",
"display": "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Trimethoprim+Sulfamethoxazole"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d40",
"resource": {
"resourceType": "Observation",
"id": "org51-nitrofurantoin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "363-2",
"display": "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Nitrofurantoin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "R",
"display": "Resistant"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d41",
"resource": {
"resourceType": "Observation",
"id": "org51-cefuroxime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51774-8",
"display": "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Cefuroxime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "R",
"display": "Resistant"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d42",
"resource": {
"resourceType": "Observation",
"id": "org51-gentamicin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "267-5",
"display": "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Gentamicin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d43",
"resource": {
"resourceType": "Observation",
"id": "org51-colistin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "205-5",
"display": "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Colistin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "R",
"display": "Resistant"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d44",
"resource": {
"resourceType": "Observation",
"id": "org51-temocillin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "492-9",
"display": "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Temocillin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d45",
"resource": {
"resourceType": "Observation",
"id": "org51-fosfomycin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "25653-7",
"display": "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Fosfomycin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d46",
"resource": {
"resourceType": "Observation",
"id": "org51-levofloxacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "20396-8",
"display": "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Levofloxacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d47",
"resource": {
"resourceType": "Observation",
"id": "org51-ofloxacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "375-6",
"display": "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ofloxacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d48",
"resource": {
"resourceType": "Observation",
"id": "org51-amoxicillin-clavulanate",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "20-8",
"display": "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Amoxicillin+Clavulanate"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "R",
"display": "Resistant"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d49",
"resource": {
"resourceType": "Observation",
"id": "org51-amikacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "12-5",
"display": "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Amikacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d50",
"resource": {
"resourceType": "Observation",
"id": "org51-piperacillin-tazobactam",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "412-7",
"display": "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Piperacillin+Tazobactam"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d51",
"resource": {
"resourceType": "Observation",
"id": "org51-ceftriaxone",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "141-2",
"display": "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ceftriaxone"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d52",
"resource": {
"resourceType": "Observation",
"id": "org51-cefotaxime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "108-1",
"display": "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Cefotaxime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d53",
"resource": {
"resourceType": "Observation",
"id": "org51-ceftazidime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "133-9",
"display": "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ceftazidime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d54",
"resource": {
"resourceType": "Observation",
"id": "org51-meropenem",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "6652-2",
"display": "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Meropenem"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d55",
"resource": {
"resourceType": "Observation",
"id": "org52",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "73960-7",
"display": "Bacteria identified in Mouth by Culture"
}
]
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "112283007",
"display": "Escherichia coli"
}
]
},
"specimen": {
"reference": "Specimen/specimen50"
},
"hasMember": [
{
"reference": "Observation/org52-ampicilin"
},
{
"reference": "Observation/org52-trimethoprim-sulfamethoxazole"
},
{
"reference": "Observation/org52-nitrofurantoin"
},
{
"reference": "Observation/org52-cefuroxime"
},
{
"reference": "Observation/org52-gentamicin"
},
{
"reference": "Observation/org52-colistin"
},
{
"reference": "Observation/org52-temocillin"
},
{
"reference": "Observation/org52-fosfomycin"
},
{
"reference": "Observation/org52-levofloxacin"
},
{
"reference": "Observation/org52-ofloxacin"
},
{
"reference": "Observation/org52-amoxicillin-clavulanate"
},
{
"reference": "Observation/org52-amikacin"
},
{
"reference": "Observation/org52-piperacillin-tazobactam"
},
{
"reference": "Observation/org52-ceftriaxone"
},
{
"reference": "Observation/org52-cefotaxime"
},
{
"reference": "Observation/org52-ceftazidime"
},
{
"reference": "Observation/org52-meropenem"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d56",
"resource": {
"resourceType": "Observation",
"id": "org52-ampicilin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "29-9",
"display": "Ampicillin [Susceptibility] by Disk diffusion (KB)"
}
]
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d57",
"resource": {
"resourceType": "Observation",
"id": "org52-trimethoprim-sulfamethoxazole",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "516-5",
"display": "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Trimethoprim+Sulfamethoxazole"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d58",
"resource": {
"resourceType": "Observation",
"id": "org52-nitrofurantoin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "363-2",
"display": "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Nitrofurantoin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d59",
"resource": {
"resourceType": "Observation",
"id": "org52-cefuroxime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51774-8",
"display": "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Cefuroxime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d60",
"resource": {
"resourceType": "Observation",
"id": "org52-gentamicin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "267-5",
"display": "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Gentamicin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d61",
"resource": {
"resourceType": "Observation",
"id": "org52-colistin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "205-5",
"display": "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Colistin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d62",
"resource": {
"resourceType": "Observation",
"id": "org52-temocillin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "492-9",
"display": "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Temocillin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d63",
"resource": {
"resourceType": "Observation",
"id": "org52-fosfomycin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "25653-7",
"display": "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Fosfomycin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d64",
"resource": {
"resourceType": "Observation",
"id": "org52-levofloxacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "20396-8",
"display": "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Levofloxacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d65",
"resource": {
"resourceType": "Observation",
"id": "org52-ofloxacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "375-6",
"display": "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ofloxacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d66",
"resource": {
"resourceType": "Observation",
"id": "org52-amoxicillin-clavulanate",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "20-8",
"display": "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Amoxicillin+Clavulanate"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d67",
"resource": {
"resourceType": "Observation",
"id": "org52-amikacin",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "12-5",
"display": "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Amikacin"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d68",
"resource": {
"resourceType": "Observation",
"id": "org52-piperacillin-tazobactam",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "412-7",
"display": "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Piperacillin+Tazobactam"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d69",
"resource": {
"resourceType": "Observation",
"id": "org52-ceftriaxone",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "141-2",
"display": "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ceftriaxone"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d70",
"resource": {
"resourceType": "Observation",
"id": "org52-cefotaxime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "108-1",
"display": "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Cefotaxime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d71",
"resource": {
"resourceType": "Observation",
"id": "org52-ceftazidime",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "133-9",
"display": "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Ceftazidime"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d72",
"resource": {
"resourceType": "Observation",
"id": "org52-meropenem",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "6652-2",
"display": "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
}
],
"text": "Meropenem"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"interpretation": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
"code": "S",
"display": "Susceptible"
}
]
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d80",
"resource": {
"resourceType": "Observation",
"id": "dr50-mrsa",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "35492-8",
"display": "Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection"
}
],
"text": "MRSA"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"valueString": "negative"
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d81",
"resource": {
"resourceType": "Observation",
"id": "dr50-mrgn",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/lab/StructureDefinition/be-observation-laboratory"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "78702-8",
"display": "Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture"
}
],
"text": "MRGN"
},
"subject": {
"reference": "Patient/patient1"
},
"effectiveDateTime": "2015-11-04T09:16:00-05:00",
"issued": "2015-11-04T09:16:00-05:00",
"performer": [
{
"reference": "Practitioner/practitioner11"
}
],
"valueString": "negative"
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d72",
"resource": {
"resourceType": "Organization",
"id": "organization10",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-organization"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"use": "official",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "MD",
"display": "Medical License number"
}
]
},
"system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value": "81165343998"
}
],
"active": true,
"type": [
{
"coding": [
{
"system": "https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty",
"code": "orglaboratory"
}
]
}
],
"name": "GTL - General Testing Laboratory",
"telecom": [
{
"system": "phone",
"value": "322675199",
"use": "work"
}
],
"address": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/language",
"valueCode": "nl"
}
],
"use": "work",
"type": "both",
"text": "Vulcansstraat 120, 1000 Brussel",
"line": [
"Vulcansstraat 120"
],
"_line": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName",
"valueString": "Vulcansstraat"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber",
"valueString": "120"
}
]
}
],
"city": "Brussel",
"postalCode": "1000",
"country": "BE"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d73",
"resource": {
"resourceType": "Practitioner",
"id": "practitioner11",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"use": "official",
"system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value": "554488997"
}
],
"name": [
{
"use": "official",
"family": "Davoust",
"given": [
"Nicolas"
]
}
],
"telecom": [
{
"system": "email",
"value": "nicolas.davoust@gtl.be",
"use": "work"
},
{
"system": "phone",
"value": "022675198",
"use": "work"
},
{
"system": "fax",
"value": "022675209",
"use": "work"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d74",
"resource": {
"resourceType": "Patient",
"id": "patient1",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-patient"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"use": "official",
"system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin",
"value": "79121137740"
}
],
"active": true,
"name": [
{
"family": "La Paradisio",
"given": [
"Josephine",
"Nessa"
]
}
],
"telecom": [
{
"system": "email",
"value": "nessa.laparadisio@belgium.be"
},
{
"system": "phone",
"value": "+322476792979",
"use": "mobile"
},
{
"system": "phone",
"value": "+3226718655",
"use": "home"
},
{
"system": "phone",
"value": "+322476799",
"use": "work"
}
],
"gender": "female",
"birthDate": "1979-12-11",
"_birthDate": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/patient-birthTime",
"valueDateTime": "1979-12-11T13:28:17-05:00"
}
]
},
"address": [
{
"use": "home",
"type": "both",
"text": "Sloordelle 42, 1160 Oudergem",
"line": [
"Sloordelle 42"
],
"city": "Oudergem",
"postalCode": "1160",
"country": "BE"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d75",
"resource": {
"resourceType": "ServiceRequest",
"id": "servicerequest50",
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"system": "https://www.GTL-LABO.be/orderingsystem",
"value": "12334546"
}
],
"status": "active",
"intent": "order",
"category": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "108252007",
"display": "Laboratory procedure"
}
]
}
],
"subject": {
"reference": "Patient/patient1"
},
"authoredOn": "2015-11-01T14:41:00+01:00",
"requester": {
"reference": "Practitioner/practitioner1"
},
"specimen": [
{
"reference": "Specimen/specimen50"
}
]
}
},
{
"fullUrl": "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d76",
"resource": {
"resourceType": "Practitioner",
"id": "practitioner1",
"meta": {
"profile": [
"https://www.ehealth.fgov.be/standards/fhir/core/StructureDefinition/be-practitioner"
]
},
"text": {
"status": "empty",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>"
},
"identifier": [
{
"use": "official",
"system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi",
"value": "18749704477"
}
],
"name": [
{
"use": "official",
"family": "Pulaski",
"given": [
"Katherine"
],
"suffix": [
"MD"
]
}
],
"telecom": [
{
"system": "email",
"value": "katherine.pulaski@enterprisehospital.be",
"use": "work"
},
{
"system": "phone",
"value": "022675198",
"use": "work"
},
{
"system": "fax",
"value": "022675209",
"use": "work"
}
],
"address": [
{
"use": "home",
"text": "Jupiterlaan 5, 1853 Grimbergen",
"line": [
"Jupiterlaan 5"
],
"city": "Grimbergen",
"postalCode": "1853",
"country": "BE"
}
]
}
}
]
}